Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Laminin 2 alpha ELISA Kit (AC2802)
Cat.#: ASET-1391
Specifications
Description Human Laminin 2 alpha ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Laminin 2 alpha concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.29 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 4-64 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1604 Rabbit IL-6 ELISA Kit (AC3015) Quantitative inquiry ASET-2003 Mouse EDG8 ELISA Kit (AC3414) Quantitative inquiry ASET-2218 Human POMT1 ELISA Kit (AC3629) Quantitative inquiry ASET-1760 Human GLP-1R ELISA Kit (AC3171) Quantitative inquiry ASET-2019 Rat CD45 ELISA Kit (AC3430) Quantitative inquiry ASET-1241 Rat Wnt5a ELISA Kit (AC2652) Quantitative inquiry ASET-1505 Human Eph Receptor A2 ELISA Kit (AC2916) Quantitative inquiry ASET-2283 Human Vimentin ELISA Kit (AC3694) Quantitative inquiry ASET-1294 Rat beta Arrestin 1 ELISA Kit (AC2705) Quantitative inquiry ASET-2230 Rat CD97 ELISA Kit (AC3641) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket